Cobra licenses DNA process to AstraZeneca
Cobra Biomanufacturing has granted AstraZeneca the right to use its proprietary DNA manufacturing process to make nucleic acids for use in its drug discovery operations.
Archives for April 8, 2004
Chemotaxis screen could yield new immune system drugs
Researchers studying cell migration and the screening of drug compounds, can benefit from a new type of cell analysis system developed by Guava Technologies. These processes are extensively studied in cancer research and drug discovery labs.
Gene finding could yield improved smallpox vaccine
Scientists studying vaccinia virus, a close relative of smallpox, have discovered that a gene necessary for virus replication also plays a key role in turning off inflammation, a crucial antiviral immune response of host cells.